DOAJ
Open Access
2024
CSF proteins of inflammation, proteolysis and lipid transport define preclinical AD and progression to AD dementia in cognitively unimpaired individuals
Marta del Campo
Carlos Quesada
Lisa Vermunt
Carel F. W. Peeters
Yanaika S. Hok-A-Hin
+7 lainnya
Abstrak
Abstract This preclinical AD CSF proteome study identified a panel of 12-CSF markers detecting amyloid positivity and clinical progression to AD with high accuracy; some of these CSF proteins related to immune function, neurotrophic processes, energy metabolism and endolysosomal functioning (e.g., ITGB2, CLEC5A, IGFBP-1, CST3) changed before amyloid positivity is established.
Topik & Kata Kunci
Penulis (12)
M
Marta del Campo
C
Carlos Quesada
L
Lisa Vermunt
C
Carel F. W. Peeters
Y
Yanaika S. Hok-A-Hin
C
Calvin Trieu
A
Anouk den Braber
I
Inge M. W. Verberk
P
Pieter J. Visser
B
Betty M. Tijms
W
Wiesje M. van der Flier
C
Charlotte E. Teunissen
Format Sitasi
Campo, M.d., Quesada, C., Vermunt, L., Peeters, C.F.W., Hok-A-Hin, Y.S., Trieu, C. et al. (2024). CSF proteins of inflammation, proteolysis and lipid transport define preclinical AD and progression to AD dementia in cognitively unimpaired individuals. https://doi.org/10.1186/s13024-024-00767-z
Akses Cepat
Informasi Jurnal
- Tahun Terbit
- 2024
- Sumber Database
- DOAJ
- DOI
- 10.1186/s13024-024-00767-z
- Akses
- Open Access ✓